Biden wants Medicare, Medicaid to cover pricey weight loss drugs such as Wegovy
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
Eli Lilly, Novo Nordisk Stocks Gain as Biden Moves to Expand Coverage of Weight-Loss Drugs
Eli Lilly and Novo Nordisk shares rose Tuesday after the Biden administration proposed expanding coverage of the companies' popular weight-loss drugs in government-backed healthcare plans including ...
FDA approves Omron AI-powered AFib detection in blood pressure monitors
In October 2024, Omron Healthcare received de novo authorisation from the US Food and Drugs Administration (FDA) to market ...
Joplin Globe7d
DentalMonitoring Software Major Update Includes FDA Validated AI-Driven Clinical Indications For Orthodontic Patients
DentalMonitoring supports orthodontists with useful clinical data and is not to be used as a replacement for orthodontic care ...
HotCopper.com on MSN8d
PainChek seeks FDA tick for its PainChek Adult App
PainChek (ASX:PCK) has applied for Food and Drug Administration (FDA) De Novo approval for its new PainChek Adult App. The ...
Medical Design and Outsourcing8d
A surgical robotics co-founder offers lessons from the de novo pathway
After winning FDA authorization for CMR's Versius, Slack offered advice for navigating the de novo pathway and new ...
Crain's Chicago Business9d
Omron's first-of-its-kind home A-fib monitor moving forward
The first blood pressure monitor of its kind was granted De Novo authorization by the U.S. Food & Drug Administration as a ...
ahajournals.org14d
Abstract 4136584: The Association of De Novo Niacin Use with Long-Term Mortality
Methods: In a nationwide historical cohort of 1,139,630 US Veterans with normal baseline kidney function, we examined the association of de novo niacin prescription from 2004 to 2006 with all-cause ...
BioSpace14d
ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain
“Today’s De Novo approval will give confidence to all our current and ... Chief Business Officer and Biologics and Drug Delivery Leader at ClearPoint Neuro. “We offer a complete medical device ...
Longview News-Journal15d
SONOMOTION ANNOUNCES FDA DE NOVO CLEARANCE FOR ITS STONE CLEAR™ DEVICE
SonoMotion, a VC-backed startup based in San Mateo, CA, is a clinical stage medical technology company developing next generation non-invasive solutions for the treatment of kidney stones.
urologytimes15d
FDA grants de novo clearance to Stone Clear device
The FDA has granted de novo clearance to the Stone Clear device ... showed that ultrasonic propulsion reduced relapse (defined as stone growth, a stone-related urgent medical visit, or surgery) and ...